[DOI] [PMC free article] [PubMed] [Google Scholar] 254.Dekker L.V., Leitges M., Altschuler G., Mistry N., McDermott A., Roes J., Segal A.W
GIP (Glucose-dependent Insulinotropic Polypeptide) receptor agonists , like tirzepatide , take weight management a step further by activating both GLP-1 and GIP receptors
For example, individuals who travel frequently for work may prefer weekend mornings when they are more likely to be at their primary residence with access to proper refrigeration and injection supplies
It certainly can, and it makes sense when you think about it
Primary and secondary endpoints: For a POC study, the chosen primary outcome measures, specifically the incidence of treatment-emergent adverse events, are appropriate as ensuring the drug is safe at this stage is critical